Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GAS Pharyngitis Human Challenge Model
NCT03361163Phase 1Completed
- Start
- Jul 2018
- Primary completion
- Sep 2019
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial. Primary endpoint: Proportion of participants at each GAS M75 dose level meeting the study pharyngitis endpoint at 6 days. Started Jul 2018; status: completed.
Beyond the preview
Go deeper on NCT03361163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03361163.